NC LES 01 · 2026/27
PCQOF — Proactive Care Quality & Outcomes Framework
Previously known as ICCQ
Last update
22 September 2026
Data source
Clinical system
Refresh
Weekly · live
Next refresh
Auto · weekly
KPIs on target
2/23
21 below · 10 monitoring
Performance
42.7%
22 payment KPIs
Highest performing
CVD02
73.8% · target 64% · +9.8%
6,707 / 9,094
Lowest performing
CVD04
0% · target 92% · -92%
0 / 1,153
Most improved
—
Needs 2+ uploads
On target (2)Near target (3)Below target (21)No data (7)Mon= Monitoring only — no payment threshold
| Indicator⇅ | Target⇅ | Target activity⇅ | Performance %⇅ | Activity⇅ | Population⇅ | Shortfall⇅ | Status | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Complex Care | ||||||||||||
| CC01Sociofunctional assessment done (FY)▸ | 90% | 3,208 | 50.9% | 1,815 | 3,564 | 1,393 | Below | |||||
| CC02Carer info recorded (FY)▸ | 90% | 3,208 | 53.8% | 1,919 | 3,564 | 1,289 | Below | |||||
| CC03UCP care plan [PAY]Mon▸ | Monitoring | — | — | 72 | — | — | Monitoring | |||||
| CC04Comprehensive Medication Review (FY)Mon▸ | 80% | 2,852 | 49.4% | 1,760 | 3,564 | 1,092 | Below | |||||
| CC05Prognosis discussed FYMon▸ | 50% | 821 | 24% | 394 | 1,642 | 427 | Below | |||||
| CC06Anticipatory care planning FYMon▸ | 50% | 821 | 19.8% | 325 | 1,642 | 496 | Below | |||||
| Diabetes | ||||||||||||
| DM01T2DM 8 Care Processes Completed (FY)▸ | 78% | 17,382 | 45.4% | 10,127 | 22,284 | 7,255 | Below | |||||
| DM02Digital Retinal Screening (FY)▸ | 75% | 16,713 | 45.7% | 10,190 | 22,284 | 6,523 | Below | |||||
| DM03T2DM Triple Target Completed (FY)▸ | 43% | 8,887 | 27.5% | 5,687 | 20,666 | 3,200 | Below | |||||
| Mental Health | ||||||||||||
| MH01Antipsychotic monitoring (FY)▸ | 70% | 1,058 | 30% | 454 | 1,511 | 604 | Below | |||||
| MH02MH Depot Q1 2026-2027▸ | NIS | — | — | 197 | — | — | No data | |||||
| Respiratory | ||||||||||||
| RSP01COPD Annual Review [NIS]Mon▸ | Monitoring | — | 11.7% | 360 | 3,068 | — | Monitoring | |||||
| RSP02MRC 3+ Ref to Pul Rehab (01/04/24 - 31/03/27)▸ | 65% | 925 | 62.9% | 895 | 1,422 | 30 | Near | |||||
| Cardiovascular | ||||||||||||
| CVD01Primary Prevention Statins (FY)▸ | 70% | 16,852 | 78.8% | 18,963 | 24,073 | Met | Met | |||||
| CVD02Secondary Prevention Statins (FY)▸ | 64% | 5,821 | 73.8% | 6,707 | 9,094 | Met | Met | |||||
| CVD03CVD BP <140/90 (FY)▸ | 80% | 6,738 | 57.6% | 4,851 | 8,422 | 1,887 | Below | |||||
| CVD04AF patients on anticoagulants (FY)▸ | 92% | 1,061 | 0% | — | 1,153 | 1,061 | Below | |||||
| Renal | ||||||||||||
| CKD01CKD BP <140/90 (FY)▸ | 65% | 3,877 | 57.5% | 3,430 | 5,964 | 447 | Near | |||||
| CKD02CKD ACR >70 with BP <130/80 (FY) [NIS]Mon▸ | Monitoring | — | 42.6% | 3,117 | 7,312 | — | Monitoring | |||||
| CKD03CKD Proteinuria with ACEi/ARBs (FY)▸ | 81% | 1,342 | 0% | — | 1,656 | 1,342 | Below | |||||
| CKD04CKD G2/A3 or above with ACR urine (FY)▸ | 73% | 6,135 | 46.3% | 3,888 | 8,404 | 2,247 | Below | |||||
| CKD05CKD stages 1-5 recorded (FY)▸ | 19% | 1,320 | 10.4% | 723 | 6,943 | 597 | Below | |||||
| Care Planning | ||||||||||||
| CP02Smoking Intervention (FY)▸ | 90% | 8,122 | 70.8% | 6,393 | 9,024 | 1,729 | Below | |||||
| CP03Flu Vaccination (FY)Mon▸ | 74% | 33,636 | 0.1% | 35 | 45,454 | 33,601 | Below | |||||
| CP04Care Planning completed (FY)▸ | 70–75% | 41,035 | 31.9% | 17,459 | 54,713 | 23,576 | Below | |||||
| CP05Asthma Children Care Planning completed (FY)▸ | 72% | 2,024 | 44.8% | 1,259 | 2,811 | 765 | Below | |||||
| CP06Asthma only Adults Care Planning completed (FY)▸ | 70% | 6,390 | 30% | 2,741 | 9,128 | 3,649 | Below | |||||
| CP07Wider Determinants Enquiry Recorded (Apr 2025-Mar 2027)▸ | 80% | 44,102 | 74.6% | 41,115 | 55,127 | 2,987 | Near | |||||
| NDPP | ||||||||||||
| NDPP1bValid Referrals to NDPP (FY)Mon▸ | Monitoring | — | — | 295 | — | — | Monitoring | |||||
| ADHD | ||||||||||||
| ADHD01ADHD First Review DoneMon▸ | Monitoring | — | 36.6% | 690 | 1,887 | — | Monitoring | |||||
| ADHD02ADHD Second Review DoneMon▸ | Monitoring | — | 0% | — | 1,887 | — | Monitoring | |||||
| High Risk CVD | ||||||||||||
| HRR1High Risk CVD Annual Review done (15m)▸ | 70% | 2,379 | 33.9% | 1,151 | 3,398 | 1,228 | Below | |||||
| HRR2High Risk CVD prescribe statin and lifestyle advice▸ | 60% | 2,039 | 13% | 442 | 3,398 | 1,597 | Below | |||||
Data as of 22 September 2026 · Clinical system · Refreshed weekly